ISOLATED POLYPEPTIDE POSSESSING ANTIVIRAL ACTIVITY (VARIANTS), POLYNUCLEOTIDE ENCODING ITS (VARIANTS), EXPRESSING VECTOR, RECOMBINANT CELL-HOST, METHOD FOR PREPARING POLYPEPTIDE, ANTIBODY SPECIFIC TO POLYPEPTIDE AND POLYPEPTIDE-CONTAINING PHARMACEUTICAL COMPOSITION Russian patent published in 2008 - IPC C07K14/52 C12N15/19 C12N15/63 C12N5/00 C07K16/24 C12P21/02 C12Q1/68 A61K38/19 A61P37/00 

Abstract RU 2321594 C2

FIELD: biotechnology, molecular biology, proteins.

SUBSTANCE: invention relates to a method for preparing cytokines of class II and can be used in medicine. Prepared proteins zcyto20, zcyto22, zcyto24 and zcyto25 are the most relative with interferon-α at amino acid sequence level. Receptor of cytokines of class II represents a receptor for this family of proteins. Proteins can be prepared by recombinant way using a cell-host transformed with expression vector that comprises nucleic acids corresponding to proteins. Base on proteins xcyto20, xcyto21, zcyto22, zcyto24 and zcyto25 antiviral pharmaceutical composition and specific antibodies are prepared. Invention provides preparing the novel cytokine that stimulates cells of differentiation hemopoietic line and possesses the expressed antiviral activity.

EFFECT: valuable biological and medicinal properties of polypeptide, improved preparing method.

24 cl, 21 tbl, 32 ex

Similar patents RU2321594C2

Title Year Author Number
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) 1998
  • Georgiev Georgij
  • Kiselev Sergej
  • Prokhorchuk Egor
  • Ostermann Ehlinborg
RU2238976C2
POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE 2004
  • Brehdi Lovell Dzh.
  • Klacher Kevin M.
  • Chan Chung
  • Dong Dennis L.
  • Lju Khun J.
  • Sheppard Pol O.
  • Bukovski Tomas R.
RU2372356C2
CELL-PENETRATING PEPTIDES AND POLYPEPTIDES FOR MICROORGANISM CELLS 2008
  • Ehttvud Grehm Trevor
  • Kelli,Vill'Jam Dzhon
  • Al'Termann,Ehrikh Khajnts
RU2526511C2
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) 1994
  • Lajmehn Stjuart D.
  • Bekmann M. Patritsija
RU2220979C2
PHAGE φ-mru POLYNUCLEOTIDES AND POLYPEPTIDES AND THEIR APPLICATION 2008
  • Al'Termann Ehrikh Khajnts
  • Ehttvud Grehm Trevor
  • Likhi Sinead Kristin
  • Kelli Vill'Jam Dzhon
  • Ronimus Robert Starr
  • Li Dun
  • Kun Chzhankhao
  • Skoufild Linli Rouz
  • Dej Debdzhit
  • Tutill Kehtrin Mehri
  • San Kehrri
  • Mun Kristina Dajan
  • Janssen Petrus Khendrikus
RU2520738C2
PAPILLOMAVIRUS E2 POLYPEPTIDES USED FOR VACCINATION 2008
  • Bodi Martina
  • Bajjul' Zhan-Mark
  • Sil'Vestr Natali
RU2482189C2
POLYPEPTIDES DERIVED FROM TRYPTOPHANYL-TRNA-SYNTHETASE AND USES THEREOF IN CONTROLLING OF VASCULARISATION 2002
  • Shimmel' Pol
  • Vakasugi Kejsuke
  • Frehdlehnder Martin
RU2297425C2
INTERFERON-LIKE PROTEIN ZCYTO21 2001
  • Sheppard Pol O.
  • Presnell Skott R.
  • Foks Brajan A.
  • Gilbert Tereza
  • Kholdmen Betti A.
  • Grant Frehnsis Dzh.
RU2292394C2
POLYPEPTIDE WITH ANTIVIRAL, ANTIPROLIFERATIVE AND/OR IMMUNOMODULATING ACTIVITIES, SEPARATED POLYNUCLEOTIDE 2002
  • Ehskari Zhan-Lui
RU2328528C2
POLYPEPTIDES, WHICH HAVE ANTIMICROBIAL ACTION, AND POLYNUCLEOTIDES CODING THEM 2006
  • Spodsberg Nikolaj
  • Shnorr Kerk Mehtt'Ju
RU2403260C2

RU 2 321 594 C2

Authors

Sheppard Pol O.

Foks Brajan A.

Klacher Kevin M.

Tehft Dejvid U.

Kindsvogel Uehjn R.

Dates

2008-04-10Published

2002-04-19Filed